SD (95% CI) of outcome measures at 3 and 6 month follow-ups by trial arm status
| Measure | 3 month follow-up | 6 month follow-up | ||
|---|---|---|---|---|
| Intervention | Control | Intervention | Control | |
| HbA1c | 17.6 (13.0 to 27.2) | 10.4 (7.7 to 16.1) | 16.8 (13.2 to 23.2) | 20.4 (16.0 to 28.2) |
| ADDQoL—average weighted impact score | 1.4 (1.1 to 1.9) | 2.0 (1.6 to 2.8) | 1.6 (1.2 to 2.3) | 1.9 (1.5 to 2.7) |
| Diabetes Empowerment Scale—short form | 0.5 (0.3 to 0.7) | 0.7 (0.5 to 1.0) | 0.5 (0.4 to 0.7) | 0.6 (0.5 to 0.8) |
| DSCAQ—General Diet score | 2.3 (1.8 to 3.2) | 2.3 (1.8 to 3.2) | 2.0 (1.6 to 2.8) | 2.4 (1.9 to 3.4) |
| DSCAQ—Specific Diet score | 2.1 (1.6 to 2.9) | 1.6 (1.2 to 2.2) | 1.2 (0.9 to 1.7) | 1.2 (0.9 to 1.7) |
| DSCAQ—Exercise score | 2.2 (1.7 to 3.1) | 2.4 (1.9 to 3.4) | 2.3 (1.8 to 3.3) | 2.4 (1.8 to 3.5) |
| DSCAQ—Blood Glucose Testing score | 2.0 (1.5 to 2.8) | 1.7 (1.3 to 2.4) | 2.3 (1.8 to 3.3) | 1.4 (1.1 to 2.0) |
| DSCAQ—Foot Care score | 2.3 (1.8 to 3.2) | 2.4 (1.9 to 3.4) | 2.2 (1.7 to 3.1) | 2.7 (2.1 to 3.8) |
| Diabetes Treatment Satisfaction Questionnaire score | 6.0 (4.7 to 8.4) | 6.3 (4.9 to 8.8) | 7.2 (5.5 to 10.3) | 6.4 (4.9 to 9.2) |
| Diabetes Treatment Satisfaction Questionnaire change score | 9.9 (7.7 to 13.9) | 8.3 (6.4 to 11.9) | 11.1 (8.5 to 16.0) | 11.9 (9.2 to 17.0) |
| Patient Enablement Instrument | 3.6 (2.8 to 5.1) | 4.1 (3.2 to 5.8) | 3.3 (2.5 to 4.9) | 3.9 (3.0 to 5.6) |
| Patient Report of Communication Behaviour | 6.0 (4.7 to 8.4) | 6.8 (5.3 to 9.5) | 7.3 (5.6 to 10.3) | 7.1 (5.5 to 10.0) |
ADDQoL, Audit of Diabetes-Dependent Quality of Life; HbA1c, glycosylated haemoglobin.